The division of hematology and oncology specializes in the area of cancer therapeutics, thrombosis and bleeding disorders, and the clinical care of patients with hematologic and oncologic disorders. the division has active clinical, research, and teaching programs.
Hematology and oncology patients are seen at the msu breslin cancer center. this busy clinic provides care to thousands of patients each year. physicians also provide care to inpatients, and consultation in their area of expertise. interdisciplinary cancer clinics are used to create a care team and cancer treatment plan that involves the patient, oncologists, radiation oncologists, surgeons, and other experts.
The division has an active clinical trials program that provides patients with cutting-edge treatment and helps advance the field of oncology. the division participates in national cooperative groups trials, including the national surgical adjuvant breast and bowel project (nsabp) and the southwest oncology group, both supported through the nih’s national cancer institute. in addition, the clinical trials unit conducts many other trials to advance the science and treatment of cancer.
The msu division of hematology and oncology provides acgme-based fellowship training leading to board-eligibility in both hematology and oncology. the fellowship includes scheduled didactic lectures, supervised outpatient and inpatient clinical experience, and the opportunity to do electives at other sites. residents from the department of medicine internal medicine program, chm & com medical students and repid scholars rotate through the clinical program.